Novavax is not an mRNA vaccine; early data shows it to be effective against omicron

Israel on Friday inked a deal to purchase 5 million doses of a Covid vaccine produced by the American drug manufacturer Novavax Inc.

Novavax's two-dose, protein-based vaccine can provide an alternative to those Israelis hesitate to be vaccinated with an mRNA vaccine or cannot do so for medical reasons.

Israel's Health Ministry said this would provide an element of "technological diversity" to the country's coronavirus strategy.... Read More: i24